Milne George M Jr Insider Trades

Insider Trading History

Track insider trading activity for Milne George M Jr. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Amylyx Pharmaceuticals
Amylyx Pharmaceuticals AMLX
Director
Holding Value $11.6M 812,881 shares
Last Trade
Jan 12, 2026 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$220k 17,780 shares
$12.39
$14.31
Amylyx Pharmaceuticals
Amylyx Pharmaceuticals AMLX
Director
Holding Value $358k 25,000 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$126k 25,000 shares
$5.05
$14.31
Amylyx Pharmaceuticals
Amylyx Pharmaceuticals AMLX
Director
Holding Value $11.9M 830,661 shares
Last Trade
Jan 24, 2025 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$100k 27,910 shares
$3.60
$14.31
Amylyx Pharmaceuticals
Amylyx Pharmaceuticals AMLX
Director
Holding Value $12.3M 858,571 shares
Last Trade
Sep 03, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$220k 100,000 shares
$2.20
$14.31
Amylyx Pharmaceuticals
Amylyx Pharmaceuticals AMLX
Director
Holding Value $358k 25,000 shares
Last Trade
Jun 06, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$44k 25,000 shares
$1.76
$14.31
Amylyx Pharmaceuticals
Amylyx Pharmaceuticals AMLX
Director
Holding Value $10.9M 758,571 shares
Last Trade
Jan 25, 2024 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$140k 9,100 shares
$15.37
$14.31
Amylyx Pharmaceuticals
Amylyx Pharmaceuticals AMLX
Director
Holding Value $11M 767,671 shares
Last Trade
Jan 16, 2024 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$1.46M 94,350 shares
$15.52
$14.31
Amylyx Pharmaceuticals
Amylyx Pharmaceuticals AMLX
Director
Holding Value $243k 16,985 shares
Last Trade
Jun 08, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$446k 16,985 shares
$26.25
$14.31
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals AUPH
Director
Holding Value $0 0 shares
Last Trade
May 18, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$93.8k 8,733 shares
$10.74
$16.37
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals AUPH
Director
Holding Value $1.29M 78,733 shares
Last Trade
May 18, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$93.8k 8,733 shares
$10.74
$16.37
Amylyx Pharmaceuticals
Amylyx Pharmaceuticals AMLX
Director
Holding Value $12.4M 863,937 shares
Last Trade
Mar 16, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.12M 35,000 shares
$31.89
$14.31
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals AUPH
Director
Holding Value $1.15M 70,000 shares
Last Trade
Mar 02, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$178k 20,000 shares
$8.91
$16.37
Amylyx Pharmaceuticals
Amylyx Pharmaceuticals AMLX
Director
Holding Value $272k 19,000 shares
Last Trade
Jun 09, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$258k 19,000 shares
$13.56
$14.31
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals AUPH
Director
Holding Value $143k 8,733 shares
Last Trade
May 18, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$97.9k 8,733 shares
$11.21
$16.37
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals AUPH
Director
Holding Value $819k 50,000 shares
Last Trade
Mar 04, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$54.1k 5,000 shares
$10.82
$16.37
Amylyx Pharmaceuticals
Amylyx Pharmaceuticals AMLX
Director
Holding Value $2.79M 195,081 shares
Last Trade
Jan 06, 2022 Sale
No data
No data
$14.31
Amylyx Pharmaceuticals
Amylyx Pharmaceuticals AMLX
Director
Holding Value $120k 8,400 shares
Last Trade
Jan 06, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$14.31
Amylyx Pharmaceuticals
Amylyx Pharmaceuticals AMLX
Director
Holding Value $3.17M 221,396 shares
Last Trade
Jan 06, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
No data
No data
$14.31
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals AUPH
Director
Holding Value $513k 31,347 shares
Last Trade
Jun 14, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$403k 31,347 shares
$12.86
$16.37
Charles River Laboratories International
Charles River Laboratories International CRL
Director
Holding Value $5.4M 29,079 shares
Last Trade
May 07, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$105k 307 shares
$342.55
$185.79

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up